U.S. regulators have approved a test that reportedly can predict who are at high risk for a return of cancer after surgical removal of the prostate gland.

The test, known as Prostate PX, uses advanced computer technology and digital imaging to determine an individual’s risk for a recurrence of cancer, reports The Washington Times.

Source: ScienceDaily